Eagle Pharmaceuticals Inc (EGRX) — Free Cash Flow Generation Index
Eagle Pharmaceuticals Inc (EGRX) has a Free Cash Flow Generation Index of 1.00x as of December 2022. Free cash flow of $37.55 Million represents 1% of operating cash flow ($37.56 Million). Read debt load of Eagle Pharmaceuticals Inc for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Eagle Pharmaceuticals Inc Free Cash Flow Generation Index (2016–2022)
Historical FCF Generation Index trend for Eagle Pharmaceuticals Inc across 7 annual periods. Explore Eagle Pharmaceuticals Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Eagle Pharmaceuticals Inc (2016–2022)
Year-by-year Free Cash Flow Generation Index for Eagle Pharmaceuticals Inc. For the full company profile including market capitalisation, see EGRX stock market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.00x | $30.80 Million | $30.80 Million | $178.00K | ▲ +1.2% |
| 2021 | 0.99x | $27.90 Million | $28.22 Million | $323.00K | ▲ +0.4% |
| 2020 | 0.98x | $48.75 Million | $49.50 Million | $747.00K | ▼ -0.1% |
| 2019 | 0.99x | $55.21 Million | $55.99 Million | $777.00K | ▼ -1.1% |
| 2018 | 1.00x | $52.25 Million | $52.38 Million | $133.00K | ▲ +9.4% |
| 2017 | 0.91x | $53.73 Million | $58.92 Million | $5.19 Million | ▲ +49.2% |
| 2016 | 0.61x | $32.52 Million | $53.21 Million | $20.69 Million | — |